Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BMV/ABBV stock hub

BMV/ABBV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BMV/ABBVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1T

Mexican Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BMV/ABBV

In the news

Latest news · BMV/ABBV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 12.7P50 15P75 19.8

Trailing P/E94.6

P25 19.9P50 24.1P75 31.3

ROEn/a

P25 7.7P50 12.3P75 25.2

ROIC22.2

P25 8.8P50 12.7P75 21

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BMV/ABBV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	MX
Employees	57,000
Employees Change	5,000%
Employees Change Percent	10
Enterprise value	MXN 7.2T
Exchange	Mexican Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	MXN 6.1T
Price	MXN 3,450
Price currency	MXN
Rev Per Employee	19,867,963.51x
Sector	Healthcare
Sic	2836
Symbol	bmv/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.06%
EV Earnings	111.44x
EV/EBIT	19.18x
EV/EBITDA	13.85x
EV/FCF	20.05x
EV/Sales	6.68x
FCF yield	5.88%
Forward P/E	13.5x
P/B ratio	-51.41x
P/E ratio	94.56x
P/S ratio	5.41x
PE Ratio10 Y	39.99x
PE Ratio3 Y	77.83x
PE Ratio5 Y	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.83%
EBITDA Margin	47.62%
FCF margin	31.81%
Gross margin	72.03%
Gross Profit	MXN 815.7B
Gross Profit Growth	11.06%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	3.97%
Gross Profit Growth5 Y	5.95%
Net Income	MXN 64.8B
Net Income Growth	-13.35%
Net Income Growth Q	-45.96%
Net Income Growth3 Y	-21.86%
Net Income Growth5 Y	-6.73%
Pretax Margin	9.51%
Profit Margin	5.79%
Profit Per Employee	MXN 1.1M
ROA	10.03
Roa5y	8.68
ROCE	23.19
Roe5y	1,295.2
ROIC	22.24
Roic5y	22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.63%
Cagr1y	-3.19%
Cagr3y	12.44%
Cagr5y	12.47%
Div CAGR10	12.76%
Div CAGR3	2.67%
Div CAGR5	3.27%
EPS Growth	-13.24
EPS Growth Q	-45.83
EPS Growth3 Y	-21.78
EPS Growth5 Y	-6.98
Revenue Growth	9.5x
Revenue Growth Q	12.43x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	MXN 0.46
Assets	MXN 2.5T
Cash	MXN 169.3B
Debt	MXN 1.3T
Debt EBITDA	MXN 2.41
Debt FCF	MXN 3.65
Equity	MXN -119.2B
Interest Coverage	7.52
Liabilities	MXN 2.6T
Net Cash	MXN -1.1T
Net Cash By Market Cap	MXN -18.69
Net Debt EBITDA	MXN 2.12
Net Debt FCF	MXN 3.18
Tangible Book Value	MXN -1.7T
Tangible Book Value Per Share	MXN -950
WACC	5.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	3.67
Net Working Capital	MXN -173.5B
Quick ratio	0.52
Working Capital	MXN -154.5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	-1.88%
Dividend Growth Years	2%
Dividend per share	MXN 122
Dividend Years	14
Dividend Yield	3.53%
Ex Div Date	2026-04-15
Last Dividend	MXN 29.84
Payout Frequency	Quarterly
Payout Ratio	325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	406.9%
1Y total return	-3.19%
200-day SMA	3,867.3
3Y total return	42.15%
50-day SMA	3,739.4
50-day SMA vs 200-day SMA	50under200
5Y total return	79.96%
All Time High	4,529.3
All Time High Change	-23.83%
All Time High Date	2025-03-07
All Time Low	467.1
All Time Low Change	638.54%
All Time Low Date	2013-02-01
ATR	71.72
Beta	0.31
Ch YTD	-16.05
High	3,450
High52	4,483
High52 Date	2025-10-01
High52ch	-23.04%
Low	3,450
Low52	3,420
Low52 Date	2026-04-27
Low52ch	0.88%
Ma50ch	-7.74%
Price vs 200-day SMA	-10.79%
RSI	40.14
RSI Monthly	46.04
RSI Weekly	36.73
Sharpe ratio	-0.06x
Sortino ratio	0.07
Total Return	3.48%
Tr YTD	-14.65
Tr1m	-4.2%
Tr1w	-3.9%
Tr3m	-10.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	MXN 394.4B
Operating Income Growth	15
Operating Income Growth Q	16.6
Operating Income Growth3 Y	0.7
Operating Income Growth5 Y	5.78
Operating margin	34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,680,450%
Shares Insiders	0.07%
Shares Institutions	76.02%
Shares Qo Q	0%
Shares Yo Y	0.04%
Short Ratio	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	MXN 342.4B
Average Volume	282.55x
Bv Per Share	-67.92
CAPEX	MXN -22.4B
Ch10y	232.7
Ch1m	-5.01
Ch1w	-3.9
Ch1y	-6.25
Ch3m	-11.54
Ch3y	27.64
Ch5y	49.27
Ch6m	-14.64
Change	-1.29%
Change From Open	0
Close	3,495
Days Gap	-1.29
Depreciation Amortization	139,735,481,600
Dollar Volume	258,750
Earnings Date	2026-04-29
EBIT	MXN 394.4B
EBITDA	MXN 539.3B
EPS	MXN 36.6
F Score	7
FCF	MXN 360.2B
FCF EV Yield	4.99x
Financing CF	-190,136,780,790
Fiscal Year End	December
Founded	2,012
Income Tax	MXN 42.1B
Investing CF	-116,854,708,740
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	MXN 182
Lynch Upside	-94.71
Ma150	3,878.7
Ma150ch	-11.05%
Ma20	3,563.4
Ma20ch	-3.18%
Net CF	76,004,235,120
Open	3,450
P FCF Ratio	17.01
P OCF Ratio	16.02
Payment Date	2026-05-15
Price Date	2026-05-08
Price EBITDA	MXN 11.36
Relative Volume	0.27x
Revenue	1,132,473,919,830x
SBC By Revenue	1.57x
Share Based Comp	17,829,266,730
Tax By Revenue	3.72x
Tax Rate	39.06%
Tr6m	-13.22%
Volume	75
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BMV/ABBV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.5%

$122 annual per share

Payout ratio

+325.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.3%

2 consecutive years of growth

Total shareholder yield

+3.5%

Next ex-dividend date: 2026-04-15

Performance

BMV/ABBV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BMV/ABBV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BMV/ABBV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.1

Neutral momentum band

Price vs 200-day MA

-10.8%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

-0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BMV/ABBV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bmv/ABBV stock rating?

bmv/ABBV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bmv/ABBV analysis?

The full report lives at /stocks/bmv/ABBV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bmv/ABBV?

The latest report frames bmv/ABBV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bmv/ABBV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.